Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

June 1, 2028

Study Completion Date

June 1, 2028

Conditions

In-stent Restenosis LesionCoronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))

Interventions

DRUG

Immunosuppressive therapy

prednisone + sirolimus

DRUG

Placebo

All Listed Sponsors

collaborator

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

collaborator

The First Hospital of Jilin University

OTHER

lead

China National Center for Cardiovascular Diseases

OTHER_GOV